Ionis Pharmaceuticals Inc
SWB:ISI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ionis Pharmaceuticals Inc
SWB:ISI
|
US |
|
Essential Properties Realty Trust Inc
NYSE:EPRT
|
US |
|
F
|
Fastenal Co
F:FAS
|
US |
|
B
|
Boyd Gaming Corp
F:BO5
|
US |
|
Kokuyo Co Ltd
F:KOK
|
JP |
|
US GoldMining Inc
F:Q0G
|
CA |
|
B
|
BAE Systems PLC
XBER:BSP
|
UK |
|
Ducommun Inc
NYSE:DCO
|
US |
|
Truist Financial Corp
NYSE:TFC
|
US |
|
P
|
Pernod Ricard SA
XHAM:PER
|
FR |
|
R
|
RTL Group SA
DUS:RRTL
|
LU |
Wall St Price Targets
ISI Price Targets Summary
Ionis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ISI is 78.72 EUR with a low forecast of 52.75 EUR and a high forecast of 105.11 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ISI's stock price target?
Price Target
78.72
EUR
According to Wall Street analysts, the average 1-year price target for ISI is 78.72 EUR with a low forecast of 52.75 EUR and a high forecast of 105.11 EUR.
What is the Revenue forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 26%.
What is the Gross Profit forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 8 years is 24%.
